Clotting protein replacement for von Willebrand disease
Von Willebrand factor
A clotting protein, often given with factor VIII, used by injection to treat or prevent bleeding in von Willebrand disease.
What is Von Willebrand factor?
Von Willebrand factor is a clotting protein given to people with von Willebrand disease, an inherited bleeding condition in which this protein is missing or does not work properly. It is given by injection into a vein, often together with factor VIII, to treat bleeding or to prevent it, for example around surgery or after injury. The most important risks are allergic reactions, a small risk of unwanted blood clots, and the risks that come with any plasma-derived blood product. It is a replacement treatment, used under the care of a specialist team.
Education and reference only. This is a plain-language guide to Von Willebrand factor — it deliberately contains no doses. Doses depend on the person, the brand and the reason for treatment, and belong with your prescriber. Always check the BNF, the product labelling (SmPC) and follow medical advice.
What it is
Von Willebrand factor is a protein in the blood that helps platelets stick together and stick to the wall of a blood vessel when it is injured, which is a key early step in stopping bleeding. In von Willebrand disease, this protein is missing or does not work properly, so people bruise easily and bleed more than usual, including from the nose, gums and, in women, heavily during periods. The treatment replaces this missing factor, often combined with factor VIII (another clotting protein), and is given by injection into a vein under the care of a specialist team.
How it works
Von Willebrand factor replacement works by topping up the missing or faulty clotting protein in the blood, so platelets can stick together and to the damaged vessel wall properly, helping a clot to form and stop bleeding. It also helps carry and protect factor VIII, another important clotting protein, which is why the two are often given together. Because the replaced factor is gradually cleared from the body, it is given when bleeding occurs or before a procedure that might cause bleeding, rather than as a daily medicine, although regular treatment is used for some people.
Company & origin
Originated / developed by: Specialist manufacturers.
A specialist clotting protein given by injection in the UK to treat or prevent bleeding in von Willebrand disease.
Practical use
How to take Von Willebrand factor
General, dose-free guidance — always follow your prescriber's and the leaflet's specific instructions.
- It is given by injection into a vein, planned by your specialist bleeding-disorders team.
- It is used to treat a bleed or to prevent bleeding, for example before surgery, dental work or after injury.
- It is often given together with factor VIII, as the two clotting proteins work closely together.
- Tell your team about any history of blood clots, as there is a small risk of unwanted clotting.
- Report any rash, breathlessness or swelling during treatment, as this could be an allergic reaction.
Weighing it up
Advantages & disadvantages of Von Willebrand factor
Advantages
- Effectively treats and prevents bleeding in von Willebrand disease by replacing the missing clotting protein.
- Can be used around surgery, dental work and after injury to keep bleeding under control.
- Often combined with factor VIII so both clotting proteins are supported together.
Disadvantages
- It is given by injection into a vein rather than taken by mouth.
- It carries a small risk of unwanted blood clots and of allergic reactions.
- As a plasma-derived blood product, it carries the general risks that come with such products.
Practical use
Good to know
The key thing to understand is that this is a replacement treatment for a missing clotting protein, used to treat or prevent bleeding rather than to cure the underlying condition. It is given by injection into a vein, often together with factor VIII, and your specialist haemophilia or bleeding-disorders team will plan when and how much you need, including around surgery, dental work or injury. Because it is made from human plasma, it carries the general risks of a plasma-derived blood product, though these are made very small by careful screening and treatment of the plasma. Two important safety points are the chance of an allergic reaction during treatment, and a small risk of unwanted blood clots, so your team watches for both. Always tell your team about any history of clots.
Who should not take it / use with caution
- People who have had a serious allergic reaction to a previous dose or to its ingredients should not use it.
- It is used with particular care in people who have a high risk of blood clots.
- It should only be used under the care of a specialist bleeding-disorders team.
Monitoring
- Blood tests to check clotting factor levels and guide treatment around procedures.
- Watching for allergic reactions during and after treatment.
- Watching for signs of unwanted blood clots, especially in people at higher risk.
Side effects
- Allergic-type reactions such as rash, itching or, rarely, more serious reactions.
- A small risk of unwanted blood clots, which the team watches for.
- Headache, flushing or a reaction where the injection is given in some people.
Key interactions
- Tell your team about other medicines that affect clotting or bleeding, such as blood thinners.
- Other treatments used for bleeding may be combined under specialist guidance.
- Always share your full medicines list, including any over-the-counter products.
Available as: A powder made up into a solution for injection into a vein.
Answers
Von Willebrand factor: frequently asked questions
What is von Willebrand factor used for?
It is a replacement clotting protein used to treat or prevent bleeding in von Willebrand disease, an inherited condition where this protein is missing or does not work properly.
Why is it given with factor VIII?
Von Willebrand factor helps carry and protect factor VIII, another clotting protein, so the two are often given together to control bleeding.
How is it given?
It is given by injection into a vein, planned by your specialist bleeding-disorders team, to treat a bleed or to prevent bleeding around surgery or injury.
What are the main risks?
The main risks are allergic reactions, a small chance of unwanted blood clots, and the general risks of a plasma-derived blood product, which careful screening keeps very small.
Is it a cure for von Willebrand disease?
No. It replaces the missing clotting protein to treat or prevent bleeding when needed, rather than curing the underlying inherited condition.
Authoritative sources
- BNF
- NICE CKS
Building a medicines information resource?
We create evidence-led, dose-free drug and formulary references for teams.